Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis
- 189 Downloads
YKL-40, also known as human cartilage glycoprotein 39, is a member of the “mammalian chitinase-like proteins” family without chitinase activity. Increased serum concentrations are associated with inflammatory processes and several types of cancer. In this study, we evaluated YKL-40 levels in serum and synovial fluid of patients with rheumatoid arthritis in comparison with the ultrasonographic findings. YKL-40 levels were measured by enzyme-linked immunosorbent assay in 25 patients with active rheumatoid arthritis and in 40 healthy subjects. B mode and power Doppler were performed to determine synovial thickening and vascularization. Serum YKL-40 level in patients was significantly higher than the concentration in healthy controls (P < 0.01). In patients with rheumatoid arthritis, the level of the glycoprotein in synovial fluid was remarkably elevated compared to the serum level (P = 0.003). The B mode and power Doppler scores correlated to YKL-40 in serum and synovial fluid (P = 0.07). Serum YKL-40 levels were related positively to serum markers of inflammation such as C-reactive protein (P = 0.004) and erythrocyte sedimentation rate (P = 0.003). This study is the first to demonstrate a relationship between YKL-40 levels and ultrasonographic examinations in Bulgarian patients with rheumatoid arthritis. The findings suggest that YKL-40 might be implicated in the pathogenesis of the disease and could indicate the level of joint inflammation.
KeywordsJoint sonography YKL-40 Rheumatoid arthritis
The study was supported by grants no. 1/2009 and 1/2010 from Medical University-Plovdiv.
- 16.Mandl P, Naredo E, Wakefield RG, Conaghan PG, D’agostino MA, OMERACT Ultrasound Task Force (2011) A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 38:2055–2062PubMedCrossRefGoogle Scholar
- 18.Wakefield RJ, Gibbon WW, Conaghan PG, O’Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43:2762–2770PubMedCrossRefGoogle Scholar
- 24.Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, Østergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203–214PubMedCrossRefGoogle Scholar
- 25.Knudsen LS, Hetland ML, Johansen JS, Skjodt H, Peters ND, Colic A, Grau K, Nielsen NJ, Ostergaard M (2009) Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomarker Insights 4:91–95PubMedGoogle Scholar
- 30.Syversen SW, Goll GL, Heijde D, Landeve R, Lie BA, Odegard S, Uhlig T, Gaarder PI, Kvien TK (2009) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69:345–351. doi: 10.1136/ard.2009.113092 PubMedCrossRefGoogle Scholar